IntiQuan

What IntiQuan does

IntiQuan AG is a Basel, Switzerland-headquartered clinical pharmacology and drug development services company founded in 2019 (with predecessor activity dated to 2015) employing between 11 and 50 staff. The firm delivers pharmacometric modeling and simulation (M&S) consulting alongside a proprietary software stack built around IQ Desktop, a Docker-based qualified virtual environment that packages the major M&S engines (NONMEM, MONOLIX, MATLAB, R/RStudio, PsN) into versioned images, plus IQR Tools (an R-based PK/PD modeling engine with universal syntax), IQ NCA (validated NCA against Winnonlin), IQ Report (extended Markdown-to-Word reporting), IQ Slides, IQRsbml (SBML import/export), Population Isoboles, and RHEM (open-source health economics modeling). The company serves pharmaceutical and biotechnology clients needing reproducible regulatory-grade analyses, including top-5 global pharmaceutical companies, with documented case studies spanning population QSP (90+ differential equation Rheumatoid Arthritis model), regulatory submission support (>300 page FDA reports), R-based PK/PD workflows replacing legacy stacks, and health economics modeling. In 2024 the company joined ProductLife Group to broaden combined-solution delivery and holds a strategic referral partnership with esqLABS for PBPK modeling.

Revenue is generated through three lines: (1) Pharmacometric consulting services delivered via direct enterprise engagement and CRO partnerships; (2) Strategic services covering Clinical Pharmacology, Drug Development, ADME/DMPK and Regulatory Advice; (3) Software tools and workflow solutions including IQ Desktop licensing plus open-source R packages (IQR Tools, IQ NCA, RHEM, Population Isoboles) and paid training/workshop delivery. Pricing is contact-based with no public disclosure, and lead generation combines industry workshops/webinars (with registration data shared with software partner Lixoft/MONOLIX), case-study content marketing, and direct sales to pharma and biotech organizations. Customer segments are predominantly enterprise tier-1 pharmaceutical and biotech companies plus select CRO partnerships, with the value proposition anchored on 100% computational reproducibility, reduced manual reporting errors via automated Word output, and the ability to execute analyses (e.g., complex population QSP) previously considered infeasible by client teams.

The operating geography is anchored in Switzerland (Basel headquarters at Aeschenplatz 6; legal entity IntiQuan AG, trade register CH-270.4.004.907-8), with an EEA representative office in Grenzach Wyhlen, Germany, and case-study delivery to global pharma clients. The company is privately held with no disclosed institutional funding; ownership appears founder/management-led with Stefan Wetzel as CEO. The 2024 integration with ProductLife Group represents the most material strategic shift since founding, repositioning IntiQuan from a boutique consulting outfit into a specialty practice inside a larger clinical development services group while preserving its software product line and academic-style release cadence.

Name

IntiQuan

Legal name

IntiQuan AG

Website

https://intiquan.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

IntiQuan AG is a Basel-based pharmacometric modeling and simulation consultancy and software vendor serving pharmaceutical and biotech companies. It delivers PK/PD consulting, regulatory submission support, and a Docker-based IQ Desktop virtualization platform with IQR Tools for reproducible analyses.

Ownership category

akta.pro rank

Product category

Pharmacometric Modeling and Simulation Software

NAICS

Software Publishers (5132), Other Scientific and Technical Consulting Services (54169), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

Keywords

• Pharmacometric modeling services
• Clinical pharmacology consulting
• Pharmacokinetic pharmacodynamic software
• Drug development services
• Regulatory submission support

Headquarters

HQ city

Basel

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Pharmacometric Consulting Services: High-quality integrated pharmacometric modeling and simulation consulting services supporting drug development projects across all phases. Addresses resource or expertise shortages for client organizations.
2. Strategic Services: Comprehensive services in Clinical Pharmacology, Drug Development, ADME/DMPK, and Regulatory Advice & Interactions aimed at increasing asset value.
3. Software Tools and Workflow Solutions: Computational tools including IQ Desktop, IQR Tools, IQ NCA, and IQ Report. Available as open-source R packages and/or qualified virtual environments for license.
4. Training Services: Workshops and training programs for pharmacometric modeling and simulation, with data sharing arrangements with software partners like Lixoft/MONOLIX.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

IntiQuan provides pharmacometric modeling and simulation consulting services and computational software tools for pharmaceutical and biotech drug development. Its core offerings include population PK/PD analyses, QSP modeling, clinical pharmacology strategy, and regulatory submission support, complemented by a software suite (IQ Desktop, IQR Tools, IQ NCA, IQ Report) built on R and Docker-based virtualization that delivers 100% reproducible analyses.

Product overview

IntiQuan offers an integrated portfolio of pharmacometric software tools and consulting services for Model-Informed Drug Development. The core product is IQ Desktop, a qualified virtual Modeling & Simulation environment that packages all M&S software (NONMEM, MONOLIX, MATLAB, R/Rstudio, IQR Tools, IQ NCA, IQ Report, PsN, CellDesigner) into versioned Docker-based images for 100% reproducibility. The platform is built around IQR Tools, the core R-based PK/PD modeling engine that provides a universal syntax independent of the underlying parameter estimation tool. IQ NCA adds validated noncompartmental analysis, IQ Report enables automated Word report generation from extended Markdown, and IQ Slides creates presentations. Additional tools include IQRsbml for SBML model handling, Population Isoboles for isobole analysis, and RHEM for health economics modeling. The software portfolio is complemented by pharmacometric consulting services covering clinical pharmacology, drug development, and regulatory affairs, with esqLABS as a strategic partner for PBPK modeling.

Differentiator

Problem solved

Functional benefit

Brands

• IQ Desktop: Qualified Virtual Modeling & Simulation Environment - a docker-based virtualization solution for pharmacometric modeling and simulation.
• IQR Tools
• IQ NCA
• IQ Report
• IQ Slides

Products and services

• IQ Desktop Qualified Virtual Modeling & Simulation Environment that packages pharmacometric M&S software (NONMEM, MONOLIX, MATLAB, R/Rstudio, PsN, CellDesigner, IQR Tools, IQ NCA, IQ Report) into versioned Docker-based images, ensuring 100% reproducibility of analyses at any point in time. Runs on Windows, macOS, Linux, clusters, and cloud (AWS, GCP, Azure) with minimal IT admin effort. Sold to pharmaceutical and biotech organizations for reproducible regulatory-grade modeling and simulation.
• IQR Tools State-of-the-art R-based environment for PK/PD modeling and simulation, providing a universal intuitive syntax independent of the underlying NLME tool (NONMEM, MONOLIX, NLMIXR). Enables pharmacometric analyses without requiring deep expertise in particular parameter estimation tools. Targeted at pharmaceutical and biotech modelers.
• IQ NCA R-based Noncompartmental Analysis package that computes NCA PK parameters, imports CDISC SDTM or ADaM datasets, and supports generation of submission-ready Word reports. Validated against Winnonlin with numerically identical results. Used by pharmaceutical modelers for regulatory-grade NCA analyses.
• IQ Report Extended Markdown language-based reporting tool that generates Microsoft Word documents matching customized corporate Word style templates. Enables automatic incorporation of analysis results into regulatory-ready reports without manual copy-paste. Targeted at pharmaceutical regulatory and clinical pharmacology teams.
• IQ Slides Slide generation tool for creating presentations, integrated within the IQ Desktop environment. Supports multiple aspect ratio templates in the 2026.03.12 release. Used by pharmacometric and clinical pharmacology teams to produce standardized presentations.
• IQRsbml R package providing SBML model import and export functionality for IQR Tools. Imports SBML L1 and L2 V1-4 models via the IQRmodel() function and converts IQRmodels to SBML L2 Version 4 format. Used by systems pharmacology and QSP modelers who work with SBML-compliant pathway models.
• RHEM Open-source R library for Rapid Health Economics Modeling implementing DICE (Discretely Integrated Condition Event), partitioned survival (PSM), and Markov models. Includes a JSON-based interoperability framework for standardized model representation and interfaces to Excel and heRo3. Developed for a top 5 global pharmaceutical company for health economics modeling.
• Pharmacometric Consulting Services High-quality integrated pharmacometric modeling and simulation consulting services including population PK/PD analysis, QSP modeling, regulatory submission support, clinical pharmacology strategy, and drug development expertise across all phases of drug development. Delivered to pharmaceutical and biotech clients, often complementing IQ Desktop and IQR Tools deployments.
• Strategic Services Comprehensive services in Clinical Pharmacology, Drug Development, ADME/DMPK, and Regulatory Advice & Interactions aimed at increasing asset value. Provides guidance on FDA expectations, regulatory strategy, study design, and data interpretation across single or multiple studies.

Named customers4 records

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature6 records

Partnerships

Three partnerships are on record, tiered flagship and core.

• ProductLife GroupflagshipStrategic or Co-development Partner · 1 January 2024IntiQuan joined ProductLife Group to broaden support for clients through combined solutions. This represents a significant strategic integration where IntiQuan's pharmacometric expertise complements ProductLife Group's regulatory and clinical development services.
• esqLABScoreStrategic or Co-development PartneresqLABS is a Biosimulation CRO for PBPK-based analyses supporting Formulation Development, evaluation of Drug-Drug Interactions, Pediatric and Geriatric Extrapolation Plans, and Organ-impairment Studies. IntiQuan refers clients to esqLABS for PBPK modeling services as a strategic partnership to provide comprehensive drug development support.
• Lixoft (MONOLIX)coreTechnology or IntegrationWorkshop and webinar registration data is shared with Lixoft (provider of MONOLIX software) for the provision of free software licenses needed for IntiQuan training events.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Pharmetheus: Pharmacometric consultancy offering population PK/PD, QSP, and regulatory M&S services. Closely comparable to IntiQuan in service scope and target customer profile.
• Certara: Largest dedicated pharmacometric and model-informed drug development software and services company (Phoenix WinNonlin, Pirana). Directly comparable to IntiQuan across both consulting services and PK/PD software, with overlapping customers in top global pharma.
• Metrum Research Group: Specialist pharmacometrics and clinical pharmacology services firm serving pharma and biotech. Comparable to IntiQuan as a boutique M&S consultancy focused on PK/PD, QSP, and regulatory submission support.
• Quantitative Solutions: Pharmacometrics and clinical pharmacology consultancy delivering PK/PD modeling, NCA and regulatory submission support. Directly overlapping service offerings and customer base with IntiQuan.
• PDD Consultants: Specialty pharmacometrics and biostatistics consultancy serving pharma clients across drug development. Comparable boutique model and overlap with IntiQuan's PK/PD and regulatory submission work.
• Rosa & Co: QSP-focused consulting firm delivering physiologically-based and systems pharmacology models to pharma clients. Comparable to IntiQuan in deep QSP modeling expertise and large-pharma customer base.
• esqLABS: Biosimulation CRO specializing in PBPK modeling, DDI, pediatric and organ-impairment studies. Listed as IntiQuan's strategic partner, making it a directly comparable specialty modeling services firm.
• Lixoft: Developer of MONOLIX and the broader MonolixSuite for nonlinear mixed effects modeling. IntiQuan integrates MONOLIX into IQ Desktop and refers clients for software licenses, making Lixoft a direct technology peer and ecosystem partner.

Emerging players

• Applied BioMath: QSP modeling and systems pharmacology services for biotech and pharma. Comparable niche focus on model-informed drug development with a smaller scale similar to IntiQuan.

Broad incumbents

• Simulations Plus: Public company providing modeling and simulation software (GastroPlus, MonolixSuite via Lixoft acquisition) plus services across PBPK, QSP, and clinical pharmacology. Broader portfolio than IntiQuan but overlapping customers and product categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/intiquan

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IntiQuan